Drugs / hCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06150703 Comparator | Jun 2024 → Sep 2027 expected | — | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06150703 ↗ |
| Route | Subcutaneous | “hCG 250µg subcutaneously” NCT06150703 ↗ |